Perioperative anesthesia care and tumor progression

Anesthesia and Analgesia

Volumn 124, Issue 5, 2017, Pages 1697-1708

  Sekandarzad, Mir W ^a   Van Zundert, André A J ^a   Lirk, Philipp B ^b   Doornebal, Chris W ^b   Hollmann, Markus W ^b  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYPNOTIC AGENT; INHALATION ANESTHETIC AGENT; INTRAVENOUS ANESTHETIC AGENT; LOCAL ANESTHETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PROPOFOL;

ANALGESIC ACTIVITY; ANESTHESIA; ANESTHESIOLOGIST; ANXIETY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL PRACTICE; CLINICAL TRIAL; DRUG EFFECT; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSTIMULATION; IMMUNOSUPPRESSIVE TREATMENT; NONHUMAN; NUTRITION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; REGIONAL ANESTHESIA; REVIEW; STRESS; TUMOR GROWTH; DISEASE COURSE; META ANALYSIS; NEOPLASMS; PATHOLOGY; PROCEDURES; TUMOR RECURRENCE;

ANESTHESIA; DISEASE PROGRESSION; HUMANS; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS; PERIOPERATIVE CARE;

EID: 84994565904     PISSN: 00032999     EISSN: 15267598     Source Type: Journal    
DOI: 10.1213/ANE.0000000000001652     Document Type: Review

References (155)

1. Cancer Facts & Figures 2015. Available at: Http://www.cancer. org/acs/groups/.../acspc-044552.pdf. Accessed February 15, 2016.
2. Tai LH, de Souza CT, Bélanger S, et al. Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells. Cancer Res. 2013;73:97-107.
3. Seth R, Tai LH, Falls T, et al. Surgical stress promotes the development of cancer metastases by a coagulation-dependent mechanism involving natural killer cells in a murine model. Ann Surg. 2013;258:158-168.
4. Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth. 2010;105:106-115.
5. Lim SH, Spring KJ, de Souza P, MacKenzie S, Bokey L. Circulating tumour cells and circulating nucleic acids as a measure of tumour dissemination in non-metastatic colorectal cancer surgery. Eur J Surg Oncol. 2015;41:309-314.
6. Kuo CP, Jao SW, Chen KM, et al. Comparison of the effects of thoracic epidural analgesia and i.v. infusion with lidocaine on cytokine response, postoperative pain and bowel function in patients undergoing colonic surgery. Br J Anaesth. 2006;97:640-646.
7. Sessler DI. Long-term consequences of anesthetic management. Anesthesiology. 2009;111:1-4.
8. Kurosawa S. Anesthesia in patients with cancer disorders. Curr Opin Anaesthesiol. 2012;25:376-384.
9. Ash SA, Buggy DJ. Does regional anaesthesia and analgesia or opioid analgesia influence recurrence after primary cancer surgery? An update of available evidence. Best Pract Res Clin Anaesthesiol. 2013;27:441-456.
10. Colvin LA, Fallon MT, Buggy DJ. Cancer biology, analgesics, and anaesthetics: Is there a link? Br J Anaesth. 2012;109:140-143.
11. Kavanagh T, Buggy DJ. Can anaesthetic technique effect postoperative outcome?. Curr Opin Anaesthesiol. 2012;25:185-198.
12. Gottschalk A, Sharma S, Ford J, Durieux ME, Tiouririne M. Review article: The role of the perioperative period in recurrence after cancer surgery. Anesth Analg. 2010;110:1636-1643.
13. McAlister FA, Clark HD, van Walraven C, et al. The medical review article revisited: Has the science improved? Ann Intern Med. 1999;131:947-951.
14. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: Integrating immunity's roles in cancer suppression and promotion. Science. 2011;331:1565-1570.
15. Kun L, Tang L, Wang J, Yang H, Ren J. Effect of combined general/epidural anesthesia on postoperative NK cell activity and cytokine response in gastric cancer patients undergoing radical resection. Hepatogastroenterology. 2014;61:1142-1147.
16. Chen WK, Ren L, Wei Y, Zhu DX, Miao CH, Xu JM. General anesthesia combined with epidural anesthesia ameliorates the effect of fast-track surgery by mitigating immunosuppression and facilitating intestinal functional recovery in colon cancer patients. Int J Colorectal Dis. 2015;30:475-481.
17. Meserve JR, Kaye AD, Prabhakar A, Urman RD. The role of analgesics in cancer propagation. Best Pract Res Clin Anaesthesiol. 2014;28:139-151.
18. Luo X, Zhao H, Hennah L, et al. Impact of isoflurane on malignant capability of ovarian cancer in vitro. Br J Anaesth. 2015;114:831-839.
19. Page GG, Blakely WP, Ben-Eliyahu S. Evidence that postoperative pain is a mediator of the tumor-promoting effects of surgery in rats. Pain. 2001;90:191-199.
20. Liu SS, Wu CL. The effect of analgesic technique on postoperative patient-reported outcomes including analgesia: A systematic review. Anesth Analg. 2007;105:789-808.
21. Piegeler T, Votta-Velis EG, Liu G, et al. Antimetastatic potential of amide-linked local anesthetics: Inhibition of lung adenocarcinoma cell migration and inflammatory Src signaling independent of sodium channel blockade. Anesthesiology. 2012;117:548-559.
22. Sakaguchi M, Kuroda Y, Hirose M. The antiproliferative effect of lidocaine on human tongue cancer cells with inhibition of the activity of epidermal growth factor receptor. Anesth Analg. 2006;102:1103-1107.
23. Lucchinetti E, Awad AE, Rahman M, et al. Antiproliferative effects of local anesthetics on mesenchymal stem cells: Potential implications for tumor spreading and wound healing. Anesthesiology. 2012;116:841-856.
24. Mao L, Lin S, Lin J. The effects of anesthetics on tumor progression. Int J Physiol Pathophysiol Pharmacol. 2013;5:1-10.
25. Lirk P, Berger R, Hollmann MW, Fiegl H. Lidocaine time- and dose-dependently demethylates deoxyribonucleic acid in breast cancer cell lines in vitro. Br J Anaesth. 2012;109:200-207.
26. Lirk P, Hollmann MW, Fleischer M, Weber NC, Fiegl H. Lidocaine and ropivacaine, but not bupivacaine, demethylate deoxyribonucleic acid in breast cancer cells in vitro. Br J Anaesth. 2014;113(suppl 1):i32-i38.
27. Li K, Yang J, Han X. Lidocaine sensitizes the cytotoxicity of cisplatin in breast cancer cells via up-regulation of RARβ2 and RASSF1A demethylation. Int J Mol Sci. 2014;15:23519-23536.
28. Chang YC, Liu CL, Chen MJ, et al. Local anesthetics induce apoptosis in human breast tumor cells. Anesth Analg. 2014;118:116-124.
29. Schlagenhauff B, Ellwanger U, Breuninger H, Stroebel W, Rassner G, Garbe C. Prognostic impact of the type of anaesthesia used during the excision of primary cutaneous melanoma. Melanoma Res. 2000;10:165-169.
30. Yardeni IZ, Beilin B, Mayburd E, Levinson Y, Bessler H. The effect of perioperative intravenous lidocaine on postoperative pain and immune function. Anesth Analg. 2009;109:1464-1469.
31. US National Library of Medicine. IV lidocaine for patients undergoing primary breast cancer surgery: Effects on postoperative recovery and cancer recurrence. Available at: Https://clinicaltrials. gov/ct2/show/NCT01204242?term=Regional+Anesthesia+a nd+Cancer+recurrence&rank=9. Accessed February 15, 2016.
32. Fairhurst C, Watt I, Martin F, Bland M, Brackenbury WJ. Sodium channel-inhibiting drugs and survival of breast, colon and prostate cancer: A population-based study. Sci Rep. 2015;5:16758.
33. Biki B, Mascha E, Moriarty DC, Fitzpatrick JM, Sessler DI, Buggy DJ. Anesthetic technique for radical prostatectomy surgery affects cancer recurrence: A retrospective analysis. Anesthesiology. 2008;109:180-187.
34. Wuethrich PY, Hsu Schmitz SF, Kessler TM, et al. Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: A retrospective study. Anesthesiology. 2010;113:570-576.
35. de Oliveira GS Jr., Ahmad S, Schink JC, Singh DK, Fitzgerald PC, McCarthy RJ. Intraoperative neuraxial anesthesia but not postoperative neuraxial analgesia is associated with increased relapse-free survival in ovarian cancer patients after primary cytoreductive surgery. Reg Anesth Pain Med. 2011;36:271-277.
36. Gupta A, Björnsson A, Fredriksson M, Hallböök O, Eintrei C. Reduction in mortality after epidural anaesthesia and analgesia in patients undergoing rectal but not colonic cancer surgery: A retrospective analysis of data from 655 patients in central Sweden. Br J Anaesth. 2011;107:164-170.
37. Cummings KC III, Xu F, Cummings LC, Cooper GS. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: A population-based study. Anesthesiology. 2012;116:797-806.
38. Gottschalk A, Brodner G, Van Aken HK, Ellger B, Althaus S, Schulze HJ. Can regional anaesthesia for lymph-node dissection improve the prognosis in malignant melanoma? Br J Anaesth. 2012;109:253-259.
39. Holler JP, Ahlbrandt J, Burkhardt E, et al. Peridural analgesia may affect long-term survival in patients with colorectal cancer after surgery (PACO-RAS-Study): An analysis of a cancer registry. Ann Surg. 2013;258:989-993.
40. Hiller JG, Hacking MB, Link EK, Wessels KL, Riedel BJ. Perioperative epidural analgesia reduces cancer recurrence after gastro-oesophageal surgery. Acta Anaesthesiol Scand. 2014;58:281-290.
41. Scavonetto F, Yeoh TY, Umbreit EC, et al. Association between neuraxial analgesia, cancer progression, and mortality after radical prostatectomy: A large, retrospective matched cohort study. Br J Anaesth. 2014;113(suppl 1):i95-i102.
42. Exadaktylos AK, Buggy DJ, Moriarty DC, Mascha E, Sessler DI. Can anesthetic technique for primary breast cancer surgery affect recurrence or metastasis? Anesthesiology. 2006;105:660-664.
43. Christopherson R, James KE, Tableman M, Marshall P, Johnson FE. Long-term survival after colon cancer surgery: A variation associated with choice of anesthesia. Anesth Analg. 2008;107:325-332.
44. Merquiol F, Montelimard AS, Nourissat A, Molliex S, Zufferey PJ. Cervical epidural anesthesia is associated with increased cancer-free survival in laryngeal and hypopharyngeal cancer surgery: A retrospective propensity-matched analysis. Reg Anesth Pain Med. 2013;38:398-402.
45. Lin L, Liu C, Tan H, Ouyang H, Zhang Y, Zeng W. Anaesthetic technique may affect prognosis for ovarian serous adenocarcinoma: A retrospective analysis. Br J Anaesth. 2011;106:814-822.
46. Tseng KS, Kulkarni S, Humphreys EB, et al. Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: An observational study. Reg Anesth Pain Med. 2014;39:284-288.
47. Tsui BC, Rashiq S, Schopflocher D, et al. Epidural anesthesia and cancer recurrence rates after radical prostatectomy. Can J Anesth. 2010;57:107-112.
48. Forget P, Tombal B, Scholtès JL, et al. Do intraoperative analgesics influence oncological outcomes after radical prostatectomy for prostate cancer? Eur J Anaesthesiol. 2011;28:830-835.
49. Ehdaie B, Sjoberg DD, Dalecki PH, Scardino PT, Eastham JA, Amar D. Association of anesthesia technique for radical prostatectomy with biochemical recurrence: A retrospective cohort study. Can J Anesth. 2014;61:1068-1074.
50. Churruca I, Sabaté S, Mayoral JF, Carles Ortiz J, Sierra P, Puigvert F. Anaesthetic technique has not been associated with prostate cancer recurrence. Br J Anaesth. 2012;108:ii16.
51. Wuethrich PY, Thalmann GN, Studer UE, Burkhard FC. Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome: A retrospective study in patients with advanced prostate cancer. PLoS One. 2013;8:e72873.
52. Roiss M, Schiffmann J, Tennstedt P, et al. Oncological long-term outcome of 4772 patients with prostate cancer undergoing radical prostatectomy: Does the anaesthetic technique matter? Eur J Surg Oncol. 2014;40:1686-1692.
53. Sprung J, Scavonetto F, Yeoh TY, et al. Outcomes after radical prostatectomy for cancer: A comparison between general anesthesia and epidural anesthesia with fentanyl analgesia: A matched cohort study. Anesth Analg. 2014;119:859-866.
54. Koonce SL, Mclaughlin SA, Eck DL, et al. Breast cancer recurrence in patients receiving epidural and paravertebral anesthesia: A retrospective, case-control study. Middle East J Anaesthesiol. 2014;22:567-571.
55. Tsigonis AM, Al-Hamadani M, Linebarger JH, et al. Are cure rates for breast cancer improved by local and regional anesthesia? Reg Anesth Pain Med. 2016;41:339-347.
56. Ismail H, Ho KM, Narayan K, Kondalsamy-Chennakesavan S. Effect of neuraxial anaesthesia on tumour progression in cervical cancer patients treated with brachytherapy: A retrospective cohort study. Br J Anaesth. 2010;105:145-149.
57. Lacassie HJ, Cartagena J, Brañes J, Assel M, Echevarría GC. The relationship between neuraxial anesthesia and advanced ovarian cancer-related outcomes in the Chilean population. Anesth Analg. 2013;117:653-660.
58. Capmas P, Billard V, Gouy S, et al. Impact of epidural analgesia on survival in patients undergoing complete cytoreductive surgery for ovarian cancer. Anticancer Res. 2012;32:1537-1542.
59. Cummings KC III, Patel M, Htoo PT, Bakaki PM, Cummings LC, Koroukian S. A comparison of the effects of epidural analgesia versus traditional pain management on outcomes after gastric cancer resection: A population-based study. Reg Anesth Pain Med. 2014;39:200-207.
60. Heinrich S, Janitz K, Merkel S, Klein P, Schmidt J. Short- and long term effects of epidural analgesia on morbidity and mortality of esophageal cancer surgery. Langenbecks Arch Surg. 2015;400:19-26.
61. Myles PS, Peyton P, Silbert B, Hunt J, Rigg JR, Sessler DI, Investigators ATG. Perioperative epidural analgesia for major abdominal surgery for cancer and recurrence-free survival: Randomised trial. BMJ. 2011;342:d1491.
62. Gottschalk A, Ford JG, Regelin CC, et al. Association between epidural analgesia and cancer recurrence after colorectal cancer surgery. Anesthesiology. 2010;113:27-34.
63. Day A, Smith R, Jourdan I, Fawcett W, Scott M, Rockall T. Retrospective analysis of the effect of postoperative analgesia on survival in patients after laparoscopic resection of colorectal cancer. Br J Anaesth. 2012;109:185-190.
64. Binczak M, Tournay E, Billard V, Rey A, Jayr C. Major abdominal surgery for cancer: Does epidural analgesia have a longterm effect on recurrence-free and overall survival? Ann Fr Anesth Reanim. 2013;32:e81-e88.
65. Lai R, Peng Z, Chen D, et al. The effects of anesthetic technique on cancer recurrence in percutaneous radiofrequency ablation of small hepatocellular carcinoma. Anesth Analg. 2012;114:290-296.
66. Cata JP, Hernandez M, Lewis VO, Kurz A. Can regional anesthesia and analgesia prolong cancer survival after orthopaedic oncologic surgery? Clin Orthop Relat Res. 2014;472:1434-1441.
67. Vogelaar FJ, Lips DJ, van Dorsten FR, Lemmens VE, Bosscha K. Impact of anaesthetic technique on survival in colon cancer: A review of the literature. Gastroenterol Rep (Oxf). 2016;4:30-34.
68. Weng M, Chen W, Hou W, Li L, Ding M, Miao C. The effect of neuraxial anesthesia on cancer recurrence and survival after cancer surgery: An updated meta-analysis. Oncotarget. 2016;7:15262-15273.
69. Sun Y, Li T, Gan TJ. The effects of perioperative regional anesthesia and analgesia on cancer recurrence and survival after oncology surgery: A systematic review and meta-analysis. Reg Anesth Pain Med. 2015;40:589-598.
70. Cakmakkaya OS, Kolodzie K, Apfel CC, Pace NL. Anaesthetic techniques for risk of malignant tumour recurrence. Cochrane Database Syst Rev. 2014;11:CD008877.
71. Pei L, Tan G, Wang L, et al. Comparison of combined generalepidural anesthesia with general anesthesia effects on survival and cancer recurrence: A meta-analysis of retrospective and prospective studies. PLoS One. 2014;9:e114667.
72. Chen WK, Miao CH. The effect of anesthetic technique on survival in human cancers: A meta-analysis of retrospective and prospective studies. PLoS One. 2013;8:e56540.
73. Elting LS, Cooksley C, Bekele BN, et al. Generalizability of cancer clinical trial results: Prognostic differences between participants and nonparticipants. Cancer. 2006;106:2452-2458.
74. Lauer MS, D'Agostino RB Sr. The randomized registry trial- the next disruptive technology in clinical research? N Engl J Med. 2013;369:1579-1581.
75. Fröbert O, Lagerqvist B, Olivecrona GK, et al; TASTE Trial. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369:1587-1597.
76. Schneeweiss S. Learning from big health care data. N Engl J Med. 2014;370:2161-2163.
77. Dalal S, Bruera E. Access to opioid analgesics and pain relief for patients with cancer. Nat Rev Clin Oncol. 2013;10:108-116.
78. Brack A, Rittner HL, Stein C. Immunosuppressive effects of opioids-clinical relevance. J Neuroimmune Pharmacol. 2011;6:490-502.
79. Afsharimani B, Doornebal CW, Cabot PJ, Hollmann MW, Parat MO. Comparison and analysis of the animal models used to study the effect of morphine on tumour growth and metastasis. Br J Pharmacol. 2015;172:251-259.
80. Horowitz M, Neeman E, Sharon E, Ben-Eliyahu S. Exploiting the critical perioperative period to improve long-term cancer outcomes. Nat Rev Clin Oncol. 2015;12:213-226.
81. Singleton PA, Lingen MW, Fekete MJ, Garcia JG, Moss J. Methylnaltrexone inhibits opiate and VEGF-induced angiogenesis: Role of receptor transactivation. Microvasc Res. 2006;72:3-11.
82. Mathew B, Lennon FE, Siegler J, et al. The novel role of the mu opioid receptor in lung cancer progression: A laboratory investigation. Anesth Analg. 2011;112:558-567.
83. Fujioka N, Nguyen J, Chen C, et al. Morphine-induced epidermal growth factor pathway activation in non-small cell lung cancer. Anesth Analg. 2011;113:1353-1364.
84. Ecimovic P, Murray D, Doran P, McDonald J, Lambert DG, Buggy DJ. Direct effect of morphine on breast cancer cell function in vitro: Role of the NET1 gene. Br J Anaesth. 2011;107:916-923.
85. Gach K, Wyrȩbska A, Fichna J, Janecka A. The role of morphine in regulation of cancer cell growth. Naunyn Schmiedebergs Arch Pharmacol. 2011;384:221-230.
86. Farooqui M, Li Y, Rogers T, et al. COX-2 inhibitor celecoxib prevents chronic morphine-induced promotion of angiogenesis, tumour growth, metastasis and mortality, without compromising analgesia. Br J Cancer. 2007;97:1523-1531.
87. Liao SJ, Zhou YH, Yuan Y, et al. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration. Breast Cancer Res Treat. 2012;133:853-863.
88. Matzner P, Sorski L, Shaashua L, et al. Perioperative treatment with the new synthetic TLR-4 agonist GLA-SE reduces cancer metastasis without adverse effects. Int J Cancer. 2016;138:1754-1764.
89. Friesen C, Hormann I, Roscher M, et al. Opioid receptor activation triggering downregulation of cAMP improves effectiveness of anti-cancer drugs in treatment of glioblastoma. Cell Cycle. 2014;13:1560-1570.
90. Friesen C, Roscher M, Hormann I, et al. Cell death sensitization of leukemia cells by opioid receptor activation. Oncotarget. 2013;4:677-690.
91. Sacerdote P. Opioids and the immune system. Palliat Med. 2006;20(suppl 1):s9-s15.
92. + breast cancer. Pain. 2015;156:1424-1432.
93. Doornebal CW, Klarenbeek S, Braumuller TM, et al. A preclinical mouse model of invasive lobular breast cancer metastasis. Cancer Res. 2013;73:353-363.
94. Hooijmans CR, Geessink FJ, Ritskes-Hoitinga M, Scheffer GJ. A systematic review and meta-analysis of the ability of analgesic drugs to reduce metastasis in experimental cancer models. Pain. 2015;156:1835-1844.
95. Koodie L, Yuan H, Pumper JA, et al. Morphine inhibits migration of tumor-infiltrating leukocytes and suppresses angiogenesis associated with tumor growth in mice. Am J Pathol. 2014;184:1073-1084.
96. Koodie L, Ramakrishnan S, Roy S. Morphine suppresses tumor angiogenesis through a HIF-1alpha/p38MAPK pathway. Am J Pathol. 2010;177:984-997.
97. Afsharimani B, Baran J, Watanabe S, Lindner D, Cabot PJ, Parat MO. Morphine and breast tumor metastasis: The role of matrix-degrading enzymes. Clin Exp Metastasis. 2014;31:149-158.
98. Khabbazi S, Goumon Y, Parat MO. Morphine modulates interleukin-4 or breast cancer cell-induced pro-metastatic activation of macrophages. Sci Rep. 2015;5:11389.
99. Cronin-Fenton DP, Heide-Jørgensen U, Ahern TP, et al. Opioids and breast cancer recurrence: A Danish populationbased cohort study. Cancer. 2015;121:3507-3514.
100. Cata JP, Keerty V, Keerty D, et al. A retrospective analysis of the effect of intraoperative opioid dose on cancer recurrence after non-small cell lung cancer resection. Cancer Med. 2014;3:900-908.
101. Kurosaki H, Fujii K, Nishikawa K. Does remifentanil affect the incidence of colon cancer recurrence? Anesth Analg. 2012;114:S459.
102. Buggy DJ, Borgeat A, Cata J, et al. Consensus statement from the BJA Workshop on Cancer and Anaesthesia. Br J Anaesth. 2015;114:2-3.
103. Yusup G, Akutsu Y, Mutallip M, et al. A COX-2 inhibitor enhances the antitumor effects of chemotherapy and radiotherapy for esophageal squamous cell carcinoma. Int J Oncol. 2014;44:1146-1152.
104. Muraki C, Ohga N, Hida Y, et al. Cyclooxygenase-2 inhibition causes antiangiogenic effects on tumor endothelial and vascular progenitor cells. Int J Cancer. 2012;130:59-70.
105. Cathcart MC, O'Byrne KJ, Reynolds JV, O'Sullivan J, Pidgeon GP. COX-derived prostanoid pathways in gastrointestinal cancer development and progression: novel targets for prevention and intervention. Biochim Biophys Acta. 2012;1825:49-63.
106. Kashiwagi E, Shiota M, Yokomizo A, et al. Prostaglandin receptor EP3 mediates growth inhibitory effect of aspirin through androgen receptor and contributes to castration resistance in prostate cancer cells. Endocr Relat Cancer. 2013;20:431-441.
107. Chang J, Vacher J, Yao B, et al. Prostaglandin E receptor 4 (EP4) promotes colonic tumorigenesis. Oncotarget. 2015;6:33500-33511.
108. 22 murine hepatocarcinoma model. Oncol Rep. 2014;31:2252-2260.
109. Arber N, Spicak J, Rácz I, et al. Five-year analysis of the prevention of colorectal sporadic adenomatous polyps trial. Am J Gastroenterol. 2011;106:1135-1146.
110. Bertagnolli MM, Eagle CJ, Zauber AG, et al; Adenoma Prevention with Celecoxib Study Investigators. Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila). 2009;2:310-321.
111. Huang XZ, Gao P, Sun JX, et al. Aspirin and nonsteroidal antiinflammatory drugs after but not before diagnosis are associated with improved breast cancer survival: A meta-analysis. Cancer Causes Control. 2015;26:589-600.
112. Retsky M, Rogers R, Demicheli R, et al. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: Particular relevance to triple negative subgroup. Breast Cancer Res Treat. 2012;134:881-888.
113. Forget P, Bentin C, Machiels JP, Berliere M, Coulie PG, De Kock M. Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery. Br J Anaesth. 2014;113(suppl 1):i82-i87.
114. Forget P, Vandenhende J, Berliere M, et al. Do intraoperative analgesics influence breast cancer recurrence after mastectomy? A retrospective analysis. Anesth Analg. 2010;110:1630-1635.
115. Kushida A, Inada T, Shingu K. Enhancement of antitumor immunity after propofol treatment in mice. Immunopharmacol Immunotoxicol. 2007;29:477-486.
116. Miao Y, Zhang Y, Wan H, Chen L, Wang F. GABA-receptor agonist, propofol inhibits invasion of colon carcinoma cells. Biomed Pharmacother. 2010;64:583-588.
117. Inada T, Kubo K, Kambara T, Shingu K. Propofol inhibits cyclo-oxygenase activity in human monocytic THP-1 cells. Can J Anesth. 2009;56:222-229.
118. Huang H, Benzonana LL, Zhao H, et al. Prostate cancer cell malignancy via modulation of HIF-1α pathway with isoflurane and propofol alone and in combination. Br J Cancer. 2014;111:1338-1349.
119. Ren XF, Li WZ, Meng FY, Lin CF. Differential effects of propofol and isoflurane on the activation of T-helper cells in lung cancer patients. Anaesthesia. 2010;65:478-482.
120. Xu YJ, Chen WK, Zhu Y, Wang SL, Miao CH. Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer. Br J Anaesth. 2014;113(suppl 1):i49-i55.
121. Deegan CA, Murray D, Doran P, Ecimovic P, Moriarty DC, Buggy DJ. Effect of anaesthetic technique on oestrogen receptor-negative breast cancer cell function in vitro. Br J Anaesth. 2009;103:685-690.
122. Buckley A, Quaid S, Johnson P, Buggy D. Serum from women undergoing breast cancer surgery, randomized to propofol-paravertebral anaesthetic technique, maintain natural killer cell anti-tumour activity compared with sevofluraneopioid technique. Eur J Anaesthesiol. 2014;31:2.
123. Xu YJ, Li SY, Cheng Q, et al. Effects of anaesthesia on proliferation, invasion and apoptosis of LoVo colon cancer cells in vitro. Anaesthesia. 2016;71:147-154.
124. Wigmore TJ, Mohammed K, Jhanji S. Long-term survival for patients undergoing volatile versus IV anesthesia for cancer surgery: A retrospective analysis. Anesthesiology. 2016;124:69-79.
125. Shi QY, Zhang SJ, Liu L, et al. Sevoflurane promotes the expansion of glioma stem cells through activation of hypoxiainducible factors in vitro. Br J Anaesth. 2015;114:825-30.
126. Liang H, Gu M, Yang C, Wang H, Wen X, Zhou Q. Sevoflurane inhibits invasion and migration of lung cancer cells by inactivating the p38 MAPK signaling pathway. J Anesth. 2012;26:381-392.
127. Ash SA, Valchev GI, Looney M, et al. Xenon decreases cell migration and secretion of a pro-angiogenesis factor in breast adenocarcinoma cells: Comparison with sevoflurane. Br J Anaesth. 2014;113(Suppl 1):i14-i21.
128. Avdeev S, Stakheeva M, Odyshev V, Faltin V, Slonimskay E. Effect of xenon anaesthesia on relapse-free survival in treatment of breast cancer: Relation with immune status. Eur J Anaesthesiol. 2014;31:11.
129. Elias KM, Kang S, Liu X, Horowitz NS, Berkowitz RS, Frendl G. Anesthetic selection and disease-free survival following optimal primary cytoreductive surgery for stage III epithelial ovarian cancer. Ann Surg Oncol. 2015;22:1341-1348.
130. Durieux ME. Time to dial down the vaporizer?. Br J Anaesth. 2015;114:715-716.
131. Fleischmann E, Marschalek C, Schlemitz K, et al. Nitrous oxide may not increase the risk of cancer recurrence after colorectal surgery: A follow-up of a randomized controlled trial. BMC Anesthesiol. 2009;9:1.
132. Weimann J. Toxicity of nitrous oxide. Best Pract Res Clin Anaesthesiol. 2003;17:47-61.
133. Inada T, Kubo K, Shingu K. Possible link between cyclooxygenase-inhibiting and antitumor properties of propofol. J Anesth. 2011;25:569-575.
134. Page GG, Ben-Eliyahu S, Yirmiya R, Liebeskind JC. Morphine attenuates surgery-induced enhancement of metastatic colonization in rats. Pain. 1993;54:21-28.
135. Page GG, McDonald JS, Ben-Eliyahu S. Pre-operative versus postoperative administration of morphine: Impact on the neuroendocrine, behavioural, and metastatic-enhancing effects of surgery. Br J Anaesth. 1998;81:216-223.
136. Page GG, Ben-Eliyahu S. The immune-suppressive nature of pain. Semin Oncol Nurs. 1997;13:10-15.
137. Sacerdote P, Manfredi B, Bianchi M, Panerai AE. Intermittent but not continuous inescapable footshock stress affects immune responses and immunocyte beta-endorphin concentrations in the rat. Brain Behav Immun. 1994;8:251-260.
138. US National Library of Medicine. Regional anesthesia and breast cancer recurrence. Available at: Https://clinicaltrials. gov/ct2/show/NCT00418457?term=Regional+Anesthesia+a nd+Cancer+recurrence&rank=1. Accessed February 15, 2016.
139. US National Library of Medicine. Anesthesia and cancer recurrence im malignant melanoma. Available at: Https://clinicaltrials. gov/ct2/show/NCT01588847?term=Regional+Anesthesia+ and+Cancer+recurrence&rank=4. Accessed February 15, 2016.
140. US National Library of Medicine. Regional anesthesia in colon rectal surgery. Available at: Https://clinicaltrials.gov/ct2/show/NCT00684229?term=Regional+Anesthesia+and+Canc er+recurrence&rank=5. Accessed February 15, 2016.
141. US National Library of Medicine. Epidural versus patientcontrolled analgesia for reduction in long-term mortality following colorectal cancer surgery (EPICOL). Available at: Https://clinicaltrials.gov/ct2/show/NCT01318161?term =Regional+Anesthesia+and+Cancer+recurrence&rank=8. Accessed February 15, 2016.
142. Bartal I, Melamed R, Greenfeld K, et al. Immune perturbations in patients along the perioperative period: Alterations in cell surface markers and leukocyte subtypes before and after surgery. Brain Behav Immun. 2010;24:376-386.
143. Glasner A, Avraham R, Rosenne E, et al. Improving survival rates in two models of spontaneous postoperative metastasis in mice by combined administration of a beta-adrenergic antagonist and a cyclooxygenase-2 inhibitor. J Immunol. 2010;184:2449-2457.
144. Goldfarb Y, Sorski L, Benish M, Levi B, Melamed R, Ben-Eliyahu S. Improving postoperative immune status and resistance to cancer metastasis: A combined perioperative approach of immunostimulation and prevention of excessive surgical stress responses. Ann Surg. 2011;253:798-810.
145. Benish M, Bartal I, Goldfarb Y, et al. Perioperative use of betablockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor metastasis. Ann Surg Oncol. 2008;15:2042-2052.
146. Powe DG, Voss MJ, Zänker KS, et al. Beta-blocker drug therapy reduces secondary cancer formation in breast cancer and improves cancer specific survival. Oncotarget. 2010;1:628-638.
147. Jansen L, Hoffmeister M, Arndt V, Chang-Claude J, Brenner H. Stage-specific associations between beta blocker use and prognosis after colorectal cancer. Cancer. 2014;120:1178-1186.
148. Cata JP, Villarreal J, Keerty D, et al. Perioperative beta-blocker use and survival in lung cancer patients. J Clin Anesth. 2014;26:106-117.
149. Sakellakis M, Kostaki A, Starakis I, Koutras A. β-blocker use and risk of recurrence in patients with early breast cancer. Chemotherapy. 2014;60:288-289.
150. US National Library of Medicine. Perioperative administration of COX 2 inhibitors and beta blockers to women undergoing breast cancer surgery. Available at: Https://clinicaltrials.gov/ct2/show/NCT00502684?term=Regiona l+Anesthesia+and+Cancer+recurrence&rank=6. Accessed February 15, 2016.
151. Pollock GR, Van Way CW III. Immune-enhancing nutrition in surgical critical care. Mo Med. 2012;109:388-392.
152. Hao W, Wong OY, Liu X, Lee P, Chen Y, Wong KK. ω-3 fatty acids suppress inflammatory cytokine production by macrophages and hepatocytes. J Pediatr Surg. 2010;45:2412-2418.
153. Goldfarb Y, Shapiro H, Singer P, et al. Fish oil attenuates surgery-induced immunosuppression, limits post-operative metastatic dissemination and increases long-term recurrence-free survival in rodents inoculated with cancer cells. Clin Nutr. 2012;31:396-404.
154. Avraham R, Benish M, Inbar S, Bartal I, Rosenne E, Ben-Eliyahu S. Synergism between immunostimulation and prevention of surgery-induced immune suppression: An approach to reduce post-operative tumor progression. Brain Behav Immun. 2010;24:952-958.
155. Santamaria LB, Schifilliti D, La Torre D, Fodale V. Drugs of anaesthesia and cancer. Surg Oncol. 2010;19:63-81.